Status:
WITHDRAWN
Phase Analysis and Obstructive CAD on Rubidium PET
Lead Sponsor:
Emory University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
Rubidium myocardial perfusion PET is an imaging test used to diagnose patients with abnormal blood flow to the heart secondary to narrowing of the heart vessels. Phase analysis is a computer method t...
Eligibility Criteria
Inclusion
- Male or female patients
- referred for myocardial perfusion imaging for suspected obstructive CAD
- 18 years of age or older.
Exclusion
- Contraindications to regadenoson radionuclide imaging including severe reactive airway disease, unstable crescendo angina, high grade AV block, caffeine within 24 hours
- Documented prior myocardial infarction
- Severe claustrophobia
- Patients who may be pregnant.
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01840696
Start Date
October 1 2013
End Date
May 1 2014
Last Update
June 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital
Atlanta, Georgia, United States, 30322